About

Steve Bandula is a leading researcher at the intersection of interventional oncology and medical robotics, with a primary focus on improving the diagnosis and treatment of kidney and liver cancers. His work is centered on developing minimally invasive, image-guided techniques to reduce surgical overtreatment, particularly for small renal masses (SRMs), where his research has demonstrated that many incidental findings may be indolent and could be managed with less aggressive approaches. Bandula’s major contributions include pioneering the NEST (Nephron Sparing Treatment) feasibility study, which explores a cohort-embedded randomized controlled trial design to compare conservative management with active intervention for SRMs. He is also a key figure in the advancement of MRI-guided needle insertion robots, authoring a comprehensive survey on systems for liver and kidney interventions that has garnered significant attention. His innovative work on an MR-safe, double-arch needle insertion robot with a scissor-folding mechanism for abdominal percutaneous interventions, as well as a soft robotic tool feeding system, showcases his commitment to overcoming the spatial constraints of MRI environments. With his most cited work accumulating over 20 citations, Bandula is shaping the future of precision, robot-assisted cancer care.

Research Focus

Key Achievements

2
H-Index
4
Papers
37
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing <b>NE</b>phron <b>S</b>paring <b>T</b>reatment (NEST) for small renal masses
21 citations · 2019
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: University College London Hospitals NHS Foundation Trust, Wellcome / EPSRC Centre for Interventional and Surgical Sciences

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago